Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1991 | 12-1990 | 12-1989 | |
| Cash Flows From Operating Activities | |||
| Net Income | 89 | -82 | -82 |
| Depreciation Amortization | 26 | 23 | 23 |
| Other Working Capital | 41 | -44 | -44 |
| Other Operating Activity | 0 | 1 | 1 |
| Operating Cash Flow | $156 | $-102 | $-102 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -81 | -4 | -4 |
| Investing Cash Flow | $-81 | $-4 | $-4 |
| Cash Flows From Financing Activities | |||
| Other Financing Activity | -73 | 52 | 52 |
| Financing Cash Flow | $-73 | $52 | $52 |
| Beginning Cash Position | 249 | 303 | 303 |
| End Cash Position | 252 | 249 | 249 |
| Net Cash Flow | $2 | $-54 | $-54 |
| Free Cash Flow | |||
| Operating Cash Flow | 156 | -102 | -102 |
| Free Cash Flow | 156 | -102 | -102 |